The market for our AI-enabled heart failure detection tool is substantial, with an estimated size of $1 billion in the US and $4 billion globally.

Our product falls into the categories of both medical devices and software as a service (SaaS), leveraging the power of AI and advanced technology.

The market opportunity extends across key regions, including the US, European Union, and the global market.

The potential for growth is significant as our solution can be implemented in various settings, including home use, exam rooms, critical care units (CCUs), fitness centers, and pharmacies.